Abstract Submission is closed.
Monday, 15 August 2022
Closing of Abstract Submissions
Thursday, 15 – Tuesday, 27 September 2022 [Extended]
Final Notification of
Friday, 07 October 2022
Final Registration Deadline
for Abstract Presenters
A. GENERAL RULES
- Types of Presentations
- Oral Presentation
- Poster Presentation
There will be a dedicated area for posters and interactions with poster presenters. Only selected posters will be chosen for presentation at the session.
- Prizes will be awarded to the top oral and poster presentations. The winner’s details will be announced at a later date.
- Abstract Receipt Confirmation
- Upon successful submission, authors will receive an automated acknowledgement via email.
- Lack of acknowledgement will indicate we did not receive the abstract. Please get in touch with us if an acknowledgement does not follow the abstract you submitted.
- Abstracts must be received by: Closing Date: Monday, 15 August 2022, 6:00 pm SGT
- Select tracks may open for thematic late-breaking abstract submissions. More information will be available closer to the date.
- Notification of Acceptance
- The Presenting Author of each abstract accepted will be notified by email.
- Accepted abstracts will be notified by: Thursday, 15 – Tuesday, 27 September 2022.
- Upon acceptance of your abstract, the presenting author must register for the WOHC 2022 to present at the Oral Presentation or the Poster Presentation.
- The abstract will be published on the WOHC 2022 website only if the presenting author is registered and full payment is received by Friday, 07 October 2022, 6:00 pm SGT.
- No changes to accepted abstracts will be allowed.
- Travel Grants
- Information on potential travel grants and sponsorship eligibility for delegates will be forthcoming in 2022. Researchers, students and policymakers from Low-to-Middle Income Countries (LMICs) with confirmed abstract acceptances will be prioritised.
B. HOW TO SUBMIT ABSTRACTS
All abstracts must be submitted online via the WOHC 2022 website and abstracts sent by other means will not be accepted.
Should you experience any technical issues, please contact:
WOHC 2022: Organising Secretariat
Phone: +(65) 6379 5262
C. GENERAL SUBMISSION GUIDELINES
- All abstracts must be submitted online via the WOHC 2022 website.
- Abstracts must be in English only.
- The abstract should be as informative as possible, with the conclusion supported with data.
- Applicants may submit either a (1) Scientific/Research abstract or (2) Descriptive/Case Study abstract. The following structure should be followed according to the type of abstract submission:
- Scientific/Research abstract (max 300 words)
- Introduction and objectives: background and purpose of the study.
- Methods: describe appropriate experimental procedures.
- Results: summarise the results of the research.
- Conclusion: state the main conclusion(s).
- Descriptive/Case Study abstract (max 300 words)
- Purpose: background and purpose of the study.
- Methods: provide an overview of the study design.
- Focus: outline the focus of the study/particular area of interest.
- Scope: state the study's relevance, implications and future direction.
- Scientific/Research abstract (max 300 words)
- An additional guide to the abstract structure
- The title must be brief and with no more than 20 words, concise, and in CAPITAL LETTERS
- The abstract body has a maximum of 300 words only
- List no more than 10 individual authors/ co-authors for each abstract. Input the co-authors' details in the e-submission form separately.
- DO NOT identify author(s) or institution(s) in the main text.
- DO NOT include references in the abstract.
- Please use standard abbreviations, generic drug names, and place unusual abbreviations or acronyms in parentheses after first use.
- Please use the guide on abstract categories to select the most appropriate category.
- You are allowed to upload either one graph, figure, or table.
- After submission of the abstract and before the closing date, you may continue to edit the abstract.
- Abstracts will be judged solely based on the data submitted in the abstract.
- The information provided is subject to change without notice.
- All the programmes and proceedings of WOHC 2022 are subject to change without prior notice.
D. ABSTRACT SUBMISSION TOPICS
One Health Science (OHS)
Pandemic Preparedness: detect, prevent and respond
- Diagnostic and discovery platforms
- Focus on pandemic-prone pathogens
- Sharing of pathogens, resources and data
- Improving outbreak response
- Biosafety and biosecurity for outbreak prevention
- Systems for collecting clinical data
Risk Factors Driving Zoonotic Infections
- Drivers of spillover and reverse zoonosis
- Clinical, epidemiology and molecular drivers of disease susceptibility
- Predictive risk models
- Pathogenesis and modes of transmission
- Risk assessment of emerging pathogens in animal models
- Molecular epidemiology and evolution
Discovery and Surveillance
- SARS-CoV-2 and other emerging pathogens
- Neglected tropical diseases
- Vector-borne diseases
- Digital-aided events based on syndromic and genomics surveillance
Vaccines and Therapeutics for Emerging Infections
- Enabling equitable access
- Novel vaccine technology
- Platforms for universal vaccines and therapeutics
- Veterinary/One Health Vaccines
- Therapeutic antibodies
Science of Climate and Ecological Change on One Health
- Role of climate change in disease emergence
- Intervention and mitigation strategies
- Role of ecological health in One Health
Antimicrobial Resistance (AMR)
One Health approach to integrated AMR surveillance
- Standardised integrated One Health AMR and Antimicrobial use (AMU)/ Antimicrobial consumption (AMC) surveillance
- Environmental AMR monitoring
AMR interaction and transmission drivers between reservoirs in humans, animals, food and the environment
- The impact of human-animal interaction on AMR transmission
- Plasmid-mediated resistance
- Genomic data linking transmission between the different reservoirs
Policy, Environment & Biosecurity (PEB)
Globalisation and human drivers of disease in a rapidly changing world
- Globalisation as a driver of disease risk
- Economic activity and One Health risk (ie. land use; domestic animals and wildlife management)
- Human, social and ethical dimensions of outbreak preparedness and response efforts (ie. social and economic inequalities, public trust, movement restrictions)
- Social inequalities and pandemic risk
- Biosecurity concerns and One Health
Environmental change and health
- Environmental change, pathogen risk and health
- Policies, interventions and novel approaches (including private sector engagement, advocacy, etc.) to address environmental drivers of disease
- Country experience and case studies for integrating environmental perspectives into One Health
Pandemic Preparedness and Health Systems Resilience (PPHSR)
Secondary/indirect impact to human and animal health
- Ensuring the fit of key One Health models and innovations and their implementation into health systems.
- One Health perspective on bi-directional and indirect impacts on humans and animals
- Harmonisation of regulatory standards for pandemic response or research
Animal and human vaccines and other preventive interventions for pandemic preparedness
- Optimal deployment and new strategies (e.g. oral vaccines) for vaccines
- Costs, benefits and risks of animal vaccination: economics of vaccines in relation to antibiotics in agri- and agro-culture
- The impact of global vaccine inequity
- The need for the transfer of technology and innovations in low-resource settings
Impact on and Innovations in Clinical Practice (IICP)
Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians
- MDRO in patients with non-communicable diseases
- The interdependence of animal and human health - MDRO in pet animals and livestock
- Using Clinical Decision Support System (CDSS) to guide antibiotic prescriptions
- Use of bioinformatics for the control and containment of infectious diseases
- Applying One Health concepts in hospitals to counter MDRO
Management of Non-Communicable Diseases (NCD) - pivoting during a pandemic and beyond
- Chronic NCD management in outbreaks: Leveraging mobile technology to improve patient care
- Rethinking NCD care models: Lessons from COVID-19
- Impact of the COVID-19 pandemic on NCD care